Correction: Tislelizumab in Chinese patients with advanced solid tumors: an open-label, non-comparative, phase 1/2 study
Saved in:
| Format: | Article |
|---|---|
| Language: | English |
| Published: |
BMJ Publishing Group
2020-10-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/8/2/e000437corr1.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850197323428134912 |
|---|---|
| collection | DOAJ |
| format | Article |
| id | doaj-art-614b9ae82a1e4906be36384ec1899554 |
| institution | OA Journals |
| issn | 2051-1426 |
| language | English |
| publishDate | 2020-10-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | Journal for ImmunoTherapy of Cancer |
| spelling | doaj-art-614b9ae82a1e4906be36384ec18995542025-08-20T02:13:11ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262020-10-018210.1136/jitc-2019-000437corr1Correction: Tislelizumab in Chinese patients with advanced solid tumors: an open-label, non-comparative, phase 1/2 studyhttps://jitc.bmj.com/content/8/2/e000437corr1.full |
| spellingShingle | Correction: Tislelizumab in Chinese patients with advanced solid tumors: an open-label, non-comparative, phase 1/2 study Journal for ImmunoTherapy of Cancer |
| title | Correction: Tislelizumab in Chinese patients with advanced solid tumors: an open-label, non-comparative, phase 1/2 study |
| title_full | Correction: Tislelizumab in Chinese patients with advanced solid tumors: an open-label, non-comparative, phase 1/2 study |
| title_fullStr | Correction: Tislelizumab in Chinese patients with advanced solid tumors: an open-label, non-comparative, phase 1/2 study |
| title_full_unstemmed | Correction: Tislelizumab in Chinese patients with advanced solid tumors: an open-label, non-comparative, phase 1/2 study |
| title_short | Correction: Tislelizumab in Chinese patients with advanced solid tumors: an open-label, non-comparative, phase 1/2 study |
| title_sort | correction tislelizumab in chinese patients with advanced solid tumors an open label non comparative phase 1 2 study |
| url | https://jitc.bmj.com/content/8/2/e000437corr1.full |